03:12 , Jun 9, 2017 |  BC Week In Review  |  Financial News

Sirona Biochem completes C$587,000 private placement of convertible notes

On June 5, drug discovery company Sirona Biochem Corp. (TSX-V:SBM; Xetra:ZSB) raised C$587,000 ($435,554) in a private placement through the sale of 12% unsecured convertible notes which mature in 18 months and convert at C$0.18....
20:17 , Feb 10, 2017 |  BC Week In Review  |  Financial News

Sirona Biochem completes private placement of convertible notes

Endocrine/metabolic company Sirona Biochem Corp. (TSX-V:SBM; Xetra:ZSB) raised C$665,360 ($510,730) through the sale of convertible notes in a private placement on Feb. 3. The 18-month notes bear 12% interest and convert at C$0.18. Sirona Biochem...
07:00 , May 16, 2016 |  BC Week In Review  |  Financial News

Sirona Biochem completes private placement of units

Sirona Biochem Corp. (TSX-V:SBM; OTCQX:SRBCF), Vancouver, B.C.   Business: Endocrine/Metabolic   Date completed: 2016-05-11   Type: Private placement of units   Raised: C$829,500 ($640,789)   Units: 4.1 million   Price: C$0.20 (unit)   Shares after...
08:00 , Nov 3, 2014 |  BC Week In Review  |  Company News

Sirona Biochem management update

Sirona Biochem Corp. (TSX-V:SBM; OTCQX:SRBCF), Vancouver, B.C.   Business: Endocrine/Metabolic   Hired: Attila Hajdu as chief business development officer, formerly business development medical lead at GlaxoSmithKline plc  ...
07:00 , Sep 1, 2014 |  BC Week In Review  |  Financial News

Sirona Biochem completes debt financing

Sirona Biochem Corp. (TSX-V:SBM; OTCQX:SRBCF), Vancouver, B.C.   Business: Endocrine/Metabolic   Date completed: 2014-08-12   Type: Debt financing   Raised: C$1.2 million ($1.1 million)   Investors: Bpifrance; District of Haute Normandie   Note: The loan...
07:00 , Aug 18, 2014 |  BC Week In Review  |  Financial News

Sirona Biochem financial update

Sirona Biochem Corp. (TSX-V:SBM; OTCQX:SRBCF), Vancouver, B.C.   Business: Endocrine/Metabolic   Date announced: 2014-08-12   Note: Sirona secured a C$1.2 million ($1.1 million) loan co-funded from Bpifrance and the French district of Haute Normandie. The...
07:00 , Jun 30, 2014 |  BC Week In Review  |  Company News

Sirona Biochem management update

Sirona Biochem Corp. (TSX-V:SBM; OTCQX:SRBCF), Vancouver, B.C.   Business: Endocrine/Metabolic   Resigned: Neil Belenkie as CEO; Chairman Howard Verrico will serve as interim CEO  ...
07:00 , May 5, 2014 |  BC Week In Review  |  Company News

Magellan BioScience, Sirona Biochem deal

The companies partnered to prioritize technologies discovered or identified by Magellan that require Sirona's stabilization technology for safe and effective commercial applications. The companies are targeting applications that include pharmaceuticals and cosmetic and OTC consumer...
07:00 , Mar 17, 2014 |  BC Week In Review  |  Financial News

Sirona Biochem completes private placement of units

Sirona Biochem Corp. (TSXV:SBM; OTCQX:SRBCF), Vancouver, B.C.   Business: Endocrine/Metabolic   Date completed: 3/6/14   Type: Private placement of units   Raised: C$1.2 million (US$1.1 million)   Units: 9.2 million   Price: C$0.13 (unit)  ...
08:00 , Mar 3, 2014 |  BC Week In Review  |  Financial News

Sirona Biochem withdraws private placement of units

Sirona Biochem Corp. (TSX-V:SBM; OTCQX:SRBCF), Vancouver, B.C.   Business: Endocrine/Metabolic   Date announced: 2/15/14   Type: Private placement of units   Note: Sirona withdrew its private placement to sell 33.4 million units at C$0.16 for...